Correction to: The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
BMC Infect Dis
.
2020 Nov 26;20(1):895.
doi: 10.1186/s12879-020-05628-w.
Authors
Naser Gharebaghi
1
,
Rahim Nejadrahim
1
,
Seyed Jalil Mousavi
1
,
Seyyed-Reza Sadat-Ebrahimi
2
,
Reza Hajizadeh
3
Affiliations
1
Department of Infectious Diseases, Urmia University of Medical Sciences, Urmia, Iran.
2
Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Sadatr@tbzmed.ac.ir.
3
Department of Cardiology, Urmia University of Medical Sciences, Urmia, Iran. hajizadh.reza@gmail.com.
PMID:
33243191
PMCID:
PMC7689645
DOI:
10.1186/s12879-020-05628-w
Abstract
An amendment to this paper has been published and can be accessed via the original article.
Publication types
Published Erratum